To include your compound in the COVID-19 Resource Center, submit it here.

CellMax reports colorectal cancer diagnostic data

By Jennie Walters | Jan 19, 2018 | 4:55 AM GMT

CellMax Life Inc. (Sunnyvale, Calif.) reported that its CellMax-CRC colorectal cancer screening test detected colorectal cancer with 84% sensitivity and 97.3% specificity.

Read the full 226 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE